These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29020184)

  • 1. Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Byrne DD; Tate JP; Forde KA; Lim JK; Goetz MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Bedimo R; Freiberg MS; Justice AC; Kostman JR; Roy JA; Lo Re V
    Clin Infect Dis; 2017 Oct; 65(9):1542-1550. PubMed ID: 29020184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Statin Use, Intensity and Acute Liver Injury in Human Immunodeficiency Virus, Hepatitis C Virus, and Uninfected US Veterans.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):103-112. PubMed ID: 32239436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.
    Gowda C; Newcomb CW; Liu Q; Carbonari DM; Lewis JD; Forde KA; Goldberg DS; Reddy KR; Roy JA; Marks AR; Schneider JL; Kostman JR; Tate JP; Lim JK; Justice AC; Goetz MB; Corley DA; Lo Re V
    Open Forum Infect Dis; 2017; 4(2):ofx012. PubMed ID: 28470014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
    Lo Re V; Kallan MJ; Tate JP; Localio AR; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park L; Dubrow R; Reddy KR; Kostman JR; Strom BL; Justice AC
    Ann Intern Med; 2014 Mar; 160(6):369-79. PubMed ID: 24723077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
    Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
    J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    Oliver NT; Hartman CM; Kramer JR; Chiao EY
    AIDS; 2016 Oct; 30(16):2469-2476. PubMed ID: 27753678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
    Quaranta MG; Ferrigno L; Monti M; Filomia R; Biliotti E; Iannone A; Migliorino G; Coco B; Morisco F; Vinci M; D'Ambrosio R; Chemello L; Massari M; Ieluzzi D; Russo FP; Blanc P; Verucchi G; Puoti M; Rumi MG; Barbaro F; Santantonio TA; Federico A; Chessa L; Gentile I; Zuin M; Parruti G; Morsica G; Kondili LA;
    Hepatol Int; 2020 May; 14(3):362-372. PubMed ID: 32279177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
    Sulkowski MS; Thomas DL; Chaisson RE; Moore RD
    JAMA; 2000 Jan; 283(1):74-80. PubMed ID: 10632283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.
    Kramer JR; Kowalkowski MA; Duan Z; Chiao EY
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):456-62. PubMed ID: 25559606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
    Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.
    Ogdie A; Pang WG; Forde KA; Samir BD; Mulugeta L; Chang KM; Kaplan DE; Amorosa VK; Kostman JR; Reddy RK; Schumacher RH; Lo Re V
    BMC Musculoskelet Disord; 2015 Apr; 16():93. PubMed ID: 25896674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.
    Mira JA; Macías J; Girón-González JA; Merino D; González-Serrano M; Jiménez-Mejías ME; Caballero-Granado FJ; Torre-Cisneros J; Terrón A; Becker MI; Gómez-Mateos J; Arizcorreta-Yarza A; Pineda JA;
    J Antimicrob Chemother; 2006 Jul; 58(1):140-6. PubMed ID: 16720565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
    Lo Re V; Zeldow B; Kallan MJ; Tate JP; Carbonari DM; Hennessy S; Kostman JR; Lim JK; Goetz MB; Gross R; Justice AC; Roy JA
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1172-1181. PubMed ID: 28722244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.
    Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V
    J Viral Hepat; 2015 Nov; 22(11):936-47. PubMed ID: 25754215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study.
    Clement ME; Park LP; Navar AM; Okeke NL; Pencina MJ; Douglas PS; Naggie S
    Clin Infect Dis; 2016 Aug; 63(3):407-13. PubMed ID: 27143663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.